HER2-Low Breast Cancer Not a Unique Biological Entity, Researchers Say
There are “minimal prognostic differences” between HER2-low breast cancer and HER2-negative breast cancer, according to researchers.
There are “minimal prognostic differences” between HER2-low breast cancer and HER2-negative breast cancer, according to researchers.
The ONA Summit is to be held from March 17-19, 2023, as a virtual event of educational sessions targeted at oncology nurses in all roles. Attendees can earn 16 continuing education credit hours upon completion of the summit.
The vast majority also report their health care provider does not address sexual health issues.
Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.
A breast cancer survivor describes her experience with a little-discussed side effect of mastectomy.
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Over time, COVID-19 was diagnosed in younger and fitter cancer patients, and these patients were less likely to be hospitalized or die from COVID-19.
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
A case report describes an atypical presentation of multiple myeloma marked by immunogammopathy maculopathy and hyperviscosity syndrome-related retinopathy.
For five of six actinic damage and skin cancer index stages, consensus-based recommendations developed